Migraine Assessment of Current Therapy Questionnaire [MACT]

Questionnaire Description

The Migraine Assessment of Current Therapy Questionnaire (MACT) is an assessment instrument used to examine the effectiveness and appropriateness of current migraine treatment.

The questionnaire focuses on the patient’s own experience and provides a structured approach to documenting how treatment affects migraine symptoms, daily functioning, and quality of life.

By assessing the patient’s response to treatment, the questionnaire can help identify situations in which the current therapeutic approach does not provide adequate symptom relief or is associated with problems that negatively affect everyday life.

Objective

The primary objective of the MACT is the systematic assessment of current migraine treatment from the patient’s perspective.

More specifically, the instrument aims to document the perceived effectiveness of treatment in relieving migraine symptoms and to evaluate its impact on daily life and quality of life.

It may also contribute to identifying treatment-related side effects or other difficulties that could require further evaluation.

The information collected through the questionnaire can support the individualization of treatment strategies and facilitate the monitoring of patients’ responses to their current migraine therapy.

Assessment Dimensions

According to the available material, the MACT examines several aspects of migraine treatment.

Treatment Effectiveness: assesses the extent to which the current treatment provides relief from migraine symptoms.

Symptoms and Side Effects: examines the presence of treatment-related side effects and their potential impact on the patient’s daily life.

Frequency and Duration of Episodes: records information regarding the frequency and duration of migraine episodes before and after treatment initiation.

Impact on Quality of Life: evaluates whether the current therapeutic approach has contributed to improvements in the patient’s quality of life.

Scoring and Assessment

The MACT assessment process is based on patients responding to questions concerning the effectiveness of their current treatment and any associated side effects.

Responses are analyzed to provide information about the impact of treatment on migraine symptoms and the patient’s quality of life.

The available source material also refers to comparing assessment results with standards in order to determine treatment effectiveness. However, it does not provide a specific number of items, response scale, numerical scoring system, or established reference values. Therefore, these characteristics cannot be reliably specified on the basis of the available material alone.

Data Analysis

Analysis of MACT data can focus on describing the patient’s response to current migraine treatment and examining the individual treatment-related parameters covered by the questionnaire.

Relevant aspects may include perceived treatment effectiveness, the presence and impact of side effects, changes in the frequency and duration of migraine episodes, and the overall effect of treatment on quality of life.

When repeated assessments are available, responses obtained at different time points may also be compared to examine potential changes in treatment response over time.

Applications

The MACT may be used in the context of assessing and monitoring the therapeutic management of migraine.

Systematic documentation of the patient’s experience can provide useful information regarding treatment effectiveness and its impact on everyday functioning and quality of life.

The assessment may also contribute to identifying difficulties associated with the current treatment strategy and support communication between patients and healthcare professionals regarding treatment progress.

The questionnaire should not replace clinical evaluation or medical diagnosis. Instead, it may serve as a complementary method for systematically documenting the patient’s experience with migraine treatment.

References

The original document includes three references related to the assessment of migraine treatment. However, these citations contain incomplete bibliographic information, including the placeholder “Year”, as well as generic author and journal details that do not allow their reliable identification.

For this reason, the references provided in the original material require bibliographic verification before publication and should not be presented as confirmed scientific sources without further validation.